Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China
Identifieur interne : 001D97 ( Istex/Corpus ); précédent : 001D96; suivant : 001D98Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China
Auteurs : Gang Wang ; Qi Cheng ; Rui Zheng ; Yu-Yan Tan ; Xiao-Kang Sun ; Hai-Yan Zhou ; Xiao-Lai Ye ; Ying Wang ; Zeng Wang ; Bo-Min Sun ; Sheng-Di ChenSource :
- Movement Disorders [ 0885-3185 ] ; 2006-09.
English descriptors
- KwdEn :
Abstract
We investigated economic costs from patients with Parkinson's disease (PD) in Shanghai, China, which could be used as a baseline for future evaluations. Data were collected from 190 patients by interview during 1‐year period. Direct medical care costs averaged approximately Chinese yuan, renminbi (RMB) 4,305 (USD 519, or EUR 410) per year per patient, of which drugs (RMB 2,677) accounted for the major costly component. Nonmedical direct costs were much less than direct health care costs, averaging approximately RMB 3,301 (USD 398, or EUR 314). Costs due to loss of productivity averaged approximately RMB 73 (USD 8.8, or EUR 7.0) per patient per year. Taken together, the overall mean annual cost for PD in our series was approximately RMB 7,679 (USD 925, or EUR 731), and these costs accounted for around half of the mean annual income. Total cost was significantly associated with the disease severity and the frequency of outpatient visits. In addition, levodopa equivalent dose (LED) and the number of drugs being taken were also closely related with the drug cost. The results indicate that the economic burden of Chinese PD patients is heavy. © 2006 Movement Disorder Society
Url:
DOI: 10.1002/mds.20999
Links to Exploration step
ISTEX:CAB5D91625F86EA3AF87460165A4ACA5D19B1EB2Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China</title><author><name sortKey="Wang, Gang" sort="Wang, Gang" uniqKey="Wang G" first="Gang" last="Wang">Gang Wang</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Cheng, Qi" sort="Cheng, Qi" uniqKey="Cheng Q" first="Qi" last="Cheng">Qi Cheng</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Zheng, Rui" sort="Zheng, Rui" uniqKey="Zheng R" first="Rui" last="Zheng">Rui Zheng</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Tan, Yu An" sort="Tan, Yu An" uniqKey="Tan Y" first="Yu-Yan" last="Tan">Yu-Yan Tan</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Sun, Xiao Ang" sort="Sun, Xiao Ang" uniqKey="Sun X" first="Xiao-Kang" last="Sun">Xiao-Kang Sun</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Zhou, Hai An" sort="Zhou, Hai An" uniqKey="Zhou H" first="Hai-Yan" last="Zhou">Hai-Yan Zhou</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Ye, Xiao Ai" sort="Ye, Xiao Ai" uniqKey="Ye X" first="Xiao-Lai" last="Ye">Xiao-Lai Ye</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Wang, Ying" sort="Wang, Ying" uniqKey="Wang Y" first="Ying" last="Wang">Ying Wang</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Wang, Zeng" sort="Wang, Zeng" uniqKey="Wang Z" first="Zeng" last="Wang">Zeng Wang</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Sun, Bo In" sort="Sun, Bo In" uniqKey="Sun B" first="Bo-Min" last="Sun">Bo-Min Sun</name><affiliation><mods:affiliation>Department of Neurosurgery, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Chen, Sheng I" sort="Chen, Sheng I" uniqKey="Chen S" first="Sheng-Di" last="Chen">Sheng-Di Chen</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:CAB5D91625F86EA3AF87460165A4ACA5D19B1EB2</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1002/mds.20999</idno><idno type="url">https://api.istex.fr/document/CAB5D91625F86EA3AF87460165A4ACA5D19B1EB2/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001D97</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China</title><author><name sortKey="Wang, Gang" sort="Wang, Gang" uniqKey="Wang G" first="Gang" last="Wang">Gang Wang</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Cheng, Qi" sort="Cheng, Qi" uniqKey="Cheng Q" first="Qi" last="Cheng">Qi Cheng</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Zheng, Rui" sort="Zheng, Rui" uniqKey="Zheng R" first="Rui" last="Zheng">Rui Zheng</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Tan, Yu An" sort="Tan, Yu An" uniqKey="Tan Y" first="Yu-Yan" last="Tan">Yu-Yan Tan</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Sun, Xiao Ang" sort="Sun, Xiao Ang" uniqKey="Sun X" first="Xiao-Kang" last="Sun">Xiao-Kang Sun</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Zhou, Hai An" sort="Zhou, Hai An" uniqKey="Zhou H" first="Hai-Yan" last="Zhou">Hai-Yan Zhou</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Ye, Xiao Ai" sort="Ye, Xiao Ai" uniqKey="Ye X" first="Xiao-Lai" last="Ye">Xiao-Lai Ye</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Wang, Ying" sort="Wang, Ying" uniqKey="Wang Y" first="Ying" last="Wang">Ying Wang</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Wang, Zeng" sort="Wang, Zeng" uniqKey="Wang Z" first="Zeng" last="Wang">Zeng Wang</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Sun, Bo In" sort="Sun, Bo In" uniqKey="Sun B" first="Bo-Min" last="Sun">Bo-Min Sun</name><affiliation><mods:affiliation>Department of Neurosurgery, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author><author><name sortKey="Chen, Sheng I" sort="Chen, Sheng I" uniqKey="Chen S" first="Sheng-Di" last="Chen">Sheng-Di Chen</name><affiliation><mods:affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2006-09">2006-09</date><biblScope unit="vol">21</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="1439">1439</biblScope><biblScope unit="page" to="1443">1443</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">CAB5D91625F86EA3AF87460165A4ACA5D19B1EB2</idno><idno type="DOI">10.1002/mds.20999</idno><idno type="ArticleID">MDS20999</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Hoehn & Yahr stage</term><term>Parkinson's disease</term><term>costs</term><term>resource use</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We investigated economic costs from patients with Parkinson's disease (PD) in Shanghai, China, which could be used as a baseline for future evaluations. Data were collected from 190 patients by interview during 1‐year period. Direct medical care costs averaged approximately Chinese yuan, renminbi (RMB) 4,305 (USD 519, or EUR 410) per year per patient, of which drugs (RMB 2,677) accounted for the major costly component. Nonmedical direct costs were much less than direct health care costs, averaging approximately RMB 3,301 (USD 398, or EUR 314). Costs due to loss of productivity averaged approximately RMB 73 (USD 8.8, or EUR 7.0) per patient per year. Taken together, the overall mean annual cost for PD in our series was approximately RMB 7,679 (USD 925, or EUR 731), and these costs accounted for around half of the mean annual income. Total cost was significantly associated with the disease severity and the frequency of outpatient visits. In addition, levodopa equivalent dose (LED) and the number of drugs being taken were also closely related with the drug cost. The results indicate that the economic burden of Chinese PD patients is heavy. © 2006 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Gang Wang MD</name><affiliations><json:string>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</json:string></affiliations></json:item><json:item><name>Qi Cheng MD, PhD</name><affiliations><json:string>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</json:string></affiliations></json:item><json:item><name>Rui Zheng MD</name><affiliations><json:string>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</json:string></affiliations></json:item><json:item><name>Yu‐Yan Tan MD</name><affiliations><json:string>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</json:string></affiliations></json:item><json:item><name>Xiao‐Kang Sun MD</name><affiliations><json:string>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</json:string></affiliations></json:item><json:item><name>Hai‐Yan Zhou MD</name><affiliations><json:string>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</json:string></affiliations></json:item><json:item><name>Xiao‐Lai Ye MD</name><affiliations><json:string>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</json:string></affiliations></json:item><json:item><name>Ying Wang MD</name><affiliations><json:string>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</json:string></affiliations></json:item><json:item><name>Zeng Wang MD</name><affiliations><json:string>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</json:string></affiliations></json:item><json:item><name>Bo‐Min Sun MD</name><affiliations><json:string>Department of Neurosurgery, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</json:string></affiliations></json:item><json:item><name>Sheng‐Di Chen MD, PhD</name><affiliations><json:string>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Hoehn & Yahr stage</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>costs</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>resource use</value></json:item></subject><language><json:string>eng</json:string></language><abstract>We investigated economic costs from patients with Parkinson's disease (PD) in Shanghai, China, which could be used as a baseline for future evaluations. Data were collected from 190 patients by interview during 1‐year period. Direct medical care costs averaged approximately Chinese yuan, renminbi (RMB) 4,305 (USD 519, or EUR 410) per year per patient, of which drugs (RMB 2,677) accounted for the major costly component. Nonmedical direct costs were much less than direct health care costs, averaging approximately RMB 3,301 (USD 398, or EUR 314). Costs due to loss of productivity averaged approximately RMB 73 (USD 8.8, or EUR 7.0) per patient per year. Taken together, the overall mean annual cost for PD in our series was approximately RMB 7,679 (USD 925, or EUR 731), and these costs accounted for around half of the mean annual income. Total cost was significantly associated with the disease severity and the frequency of outpatient visits. In addition, levodopa equivalent dose (LED) and the number of drugs being taken were also closely related with the drug cost. The results indicate that the economic burden of Chinese PD patients is heavy. © 2006 Movement Disorder Society</abstract><qualityIndicators><score>5.475</score><pdfVersion>1.3</pdfVersion><pdfPageSize>594 x 792 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>1187</abstractCharCount><pdfWordCount>3183</pdfWordCount><pdfCharCount>19822</pdfCharCount><pdfPageCount>5</pdfPageCount><abstractWordCount>191</abstractWordCount></qualityIndicators><title>Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China</title><genre><json:string>Serial article</json:string></genre><host><volume>21</volume><pages><total>5</total><last>1443</last><first>1439</first></pages><issn><json:string>0885-3185</json:string></issn><issue>9</issue><subject><json:item><value>Research Article</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2006</publicationDate><copyrightDate>2006</copyrightDate><doi><json:string>10.1002/mds.20999</json:string></doi><id>CAB5D91625F86EA3AF87460165A4ACA5D19B1EB2</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/CAB5D91625F86EA3AF87460165A4ACA5D19B1EB2/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/CAB5D91625F86EA3AF87460165A4ACA5D19B1EB2/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/CAB5D91625F86EA3AF87460165A4ACA5D19B1EB2/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>2006</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China</title><author><persName><forename type="first">Gang</forename><surname>Wang</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation></author><author><persName><forename type="first">Qi</forename><surname>Cheng</surname><roleName type="degree">MD, PhD</roleName></persName><note type="correspondence"><p>Correspondence: Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University 20025, China</p></note><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation></author><author><persName><forename type="first">Rui</forename><surname>Zheng</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation></author><author><persName><forename type="first">Yu‐Yan</forename><surname>Tan</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation></author><author><persName><forename type="first">Xiao‐Kang</forename><surname>Sun</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation></author><author><persName><forename type="first">Hai‐Yan</forename><surname>Zhou</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation></author><author><persName><forename type="first">Xiao‐Lai</forename><surname>Ye</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation></author><author><persName><forename type="first">Ying</forename><surname>Wang</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation></author><author><persName><forename type="first">Zeng</forename><surname>Wang</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation></author><author><persName><forename type="first">Bo‐Min</forename><surname>Sun</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurosurgery, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation></author><author><persName><forename type="first">Sheng‐Di</forename><surname>Chen</surname><roleName type="degree">MD, PhD</roleName></persName><note type="correspondence"><p>Correspondence: Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University 20025, China</p></note><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2006-09"></date><biblScope unit="vol">21</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="1439">1439</biblScope><biblScope unit="page" to="1443">1443</biblScope></imprint></monogr><idno type="istex">CAB5D91625F86EA3AF87460165A4ACA5D19B1EB2</idno><idno type="DOI">10.1002/mds.20999</idno><idno type="ArticleID">MDS20999</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2006</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>We investigated economic costs from patients with Parkinson's disease (PD) in Shanghai, China, which could be used as a baseline for future evaluations. Data were collected from 190 patients by interview during 1‐year period. Direct medical care costs averaged approximately Chinese yuan, renminbi (RMB) 4,305 (USD 519, or EUR 410) per year per patient, of which drugs (RMB 2,677) accounted for the major costly component. Nonmedical direct costs were much less than direct health care costs, averaging approximately RMB 3,301 (USD 398, or EUR 314). Costs due to loss of productivity averaged approximately RMB 73 (USD 8.8, or EUR 7.0) per patient per year. Taken together, the overall mean annual cost for PD in our series was approximately RMB 7,679 (USD 925, or EUR 731), and these costs accounted for around half of the mean annual income. Total cost was significantly associated with the disease severity and the frequency of outpatient visits. In addition, levodopa equivalent dose (LED) and the number of drugs being taken were also closely related with the drug cost. The results indicate that the economic burden of Chinese PD patients is heavy. © 2006 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Parkinson's disease</term></item><item><term>Hoehn & Yahr stage</term></item><item><term>costs</term></item><item><term>resource use</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Research Article</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2005-09-30">Received</change><change when="2006-03-05">Registration</change><change when="2006-09">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/CAB5D91625F86EA3AF87460165A4ACA5D19B1EB2/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="90"><doi origin="wiley" registered="yes">10.1002/mds.v21:9</doi><numberingGroup><numbering type="journalVolume" number="21">21</numbering><numbering type="journalIssue">9</numbering></numberingGroup><coverDate startDate="2006-09">September 2006</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="210" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.20999</doi><idGroup><id type="unit" value="MDS20999"></id></idGroup><countGroup><count type="pageTotal" number="5"></count></countGroup><titleGroup><title type="articleCategory">Research Article</title><title type="tocHeading1">Research Articles</title></titleGroup><copyright ownership="thirdParty">Copyright © 2006 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2005-09-30"></event><event type="manuscriptRevised" date="2006-02-22"></event><event type="manuscriptAccepted" date="2006-03-05"></event><event type="publishedOnlineEarlyUnpaginated" date="2006-06-13"></event><event type="firstOnline" date="2006-06-13"></event><event type="publishedOnlineFinalForm" date="2006-09-20"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.6 mode:FullText source:FullText result:FullText" date="2010-04-21"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">1439</numbering><numbering type="pageLast">1443</numbering></numberingGroup><correspondenceTo>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University 20025, China</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS20999.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="3"></count><count type="referenceTotal" number="23"></count><count type="wordTotal" number="3700"></count></countGroup><titleGroup><title type="main" xml:lang="en">Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China</title><title type="short" xml:lang="en">Economic Burden of PD in Shanghai</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Gang</givenNames><familyName>Wang</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Qi</givenNames><familyName>Cheng</familyName><degrees>MD, PhD</degrees></personName><contactDetails><email>qicheng@shsmu.edu.cn</email></contactDetails></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Rui</givenNames><familyName>Zheng</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Yu‐Yan</givenNames><familyName>Tan</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Xiao‐Kang</givenNames><familyName>Sun</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au6" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Hai‐Yan</givenNames><familyName>Zhou</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au7" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Xiao‐Lai</givenNames><familyName>Ye</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au8" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Ying</givenNames><familyName>Wang</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au9" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Zeng</givenNames><familyName>Wang</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au10" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Bo‐Min</givenNames><familyName>Sun</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au11" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Sheng‐Di</givenNames><familyName>Chen</familyName><degrees>MD, PhD</degrees></personName><contactDetails><email>chen_sd@medmail.com.cn</email></contactDetails></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="CN" type="organization"><unparsedAffiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="CN" type="organization"><unparsedAffiliation>Department of Neurosurgery, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Parkinson's disease</keyword><keyword xml:id="kwd2">Hoehn & Yahr stage</keyword><keyword xml:id="kwd3">costs</keyword><keyword xml:id="kwd4">resource use</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>We investigated economic costs from patients with Parkinson's disease (PD) in Shanghai, China, which could be used as a baseline for future evaluations. Data were collected from 190 patients by interview during 1‐year period. Direct medical care costs averaged approximately Chinese yuan, renminbi (RMB) 4,305 (USD 519, or EUR 410) per year per patient, of which drugs (RMB 2,677) accounted for the major costly component. Nonmedical direct costs were much less than direct health care costs, averaging approximately RMB 3,301 (USD 398, or EUR 314). Costs due to loss of productivity averaged approximately RMB 73 (USD 8.8, or EUR 7.0) per patient per year. Taken together, the overall mean annual cost for PD in our series was approximately RMB 7,679 (USD 925, or EUR 731), and these costs accounted for around half of the mean annual income. Total cost was significantly associated with the disease severity and the frequency of outpatient visits. In addition, levodopa equivalent dose (LED) and the number of drugs being taken were also closely related with the drug cost. The results indicate that the economic burden of Chinese PD patients is heavy. © 2006 Movement Disorder Society</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Economic Burden of PD in Shanghai</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China</title></titleInfo><name type="personal"><namePart type="given">Gang</namePart><namePart type="family">Wang</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Qi</namePart><namePart type="family">Cheng</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation><description>Correspondence: Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University 20025, China</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Rui</namePart><namePart type="family">Zheng</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Yu‐Yan</namePart><namePart type="family">Tan</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Xiao‐Kang</namePart><namePart type="family">Sun</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Hai‐Yan</namePart><namePart type="family">Zhou</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Xiao‐Lai</namePart><namePart type="family">Ye</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Ying</namePart><namePart type="family">Wang</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Zeng</namePart><namePart type="family">Wang</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Bo‐Min</namePart><namePart type="family">Sun</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurosurgery, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Sheng‐Di</namePart><namePart type="family">Chen</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai, China</affiliation><description>Correspondence: Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University 20025, China</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">article</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2006-09</dateIssued><dateCaptured encoding="w3cdtf">2005-09-30</dateCaptured><dateValid encoding="w3cdtf">2006-03-05</dateValid><copyrightDate encoding="w3cdtf">2006</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="tables">3</extent><extent unit="references">23</extent><extent unit="words">3700</extent></physicalDescription><abstract lang="en">We investigated economic costs from patients with Parkinson's disease (PD) in Shanghai, China, which could be used as a baseline for future evaluations. Data were collected from 190 patients by interview during 1‐year period. Direct medical care costs averaged approximately Chinese yuan, renminbi (RMB) 4,305 (USD 519, or EUR 410) per year per patient, of which drugs (RMB 2,677) accounted for the major costly component. Nonmedical direct costs were much less than direct health care costs, averaging approximately RMB 3,301 (USD 398, or EUR 314). Costs due to loss of productivity averaged approximately RMB 73 (USD 8.8, or EUR 7.0) per patient per year. Taken together, the overall mean annual cost for PD in our series was approximately RMB 7,679 (USD 925, or EUR 731), and these costs accounted for around half of the mean annual income. Total cost was significantly associated with the disease severity and the frequency of outpatient visits. In addition, levodopa equivalent dose (LED) and the number of drugs being taken were also closely related with the drug cost. The results indicate that the economic burden of Chinese PD patients is heavy. © 2006 Movement Disorder Society</abstract><subject lang="en"><genre>Keywords</genre><topic>Parkinson's disease</topic><topic>Hoehn & Yahr stage</topic><topic>costs</topic><topic>resource use</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Research Article</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><detail type="issue"><caption>no.</caption><number>9</number></detail><extent unit="pages"><start>1439</start><end>1443</end><total>5</total></extent></part></relatedItem><identifier type="istex">CAB5D91625F86EA3AF87460165A4ACA5D19B1EB2</identifier><identifier type="DOI">10.1002/mds.20999</identifier><identifier type="ArticleID">MDS20999</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2006 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D97 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001D97 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:CAB5D91625F86EA3AF87460165A4ACA5D19B1EB2
|texte= Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China
}}
| This area was generated with Dilib version V0.6.23. |  |